Company news
4basebio PLC news in 2026
4basebio PLC's news releases, calls and decks from 2026, newest first.
Result of General Meeting
November 6, 2026
Result of Retail Offer
October 21, 2026
Posting of Circular and Notice of General Mee...
October 20, 2026
4basebio Plc - Proposed Retail Offer
October 15, 2026
Proposed Retail Offer
October 15, 2026
Results of Capital Raise
October 15, 2026
Proposed Capital Raise of New Ordinary Shares...
October 15, 2026
4basebio PLC - Half-year Report for the six months ended 30 June 2026
September 29, 2026
4basebio and TriLink BioTechnologies Partner...
September 28, 2026
4basebio Expands DNA Offering to Meet Growing...
September 7, 2026
4basebio and Genezen Enter into Strategic Col...
August 26, 2026
4basebio Plc - Grant of Options & Director/PDMR Dealing
July 22, 2026
Director Appointment
July 8, 2026
4basebio Plc - Result of AGM & Issue of Options
June 30, 2026
Notice of Investor Presentation
June 16, 2026
4basebio Appoints Dr. Jeff Coller to Strategi...
June 15, 2026
Notice of Annual General Meeting
June 5, 2026
4basebio Plc - Director Dealing
May 22, 2026
4basebio Plc - 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
May 20, 2026
Appointment of Chief Financial Officer and Bo...
May 14, 2026
4basebio Launches Enzymatic ssDNA Platform
May 11, 2026
Lease of Manufacturing Facility
March 31, 2026
Appointment of COO
March 12, 2026
4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer
March 3, 2026
Leadership Changes
February 10, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (May 2026)
Investor deck · 37 slides · May 20, 2026